Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group
2016 · European Journal of Cancer · 89 citations
https://doi.org/10.1016/j.ejca.2016.03.075
L
L. Claude
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
215
Papers
3.5K
Citations
28
h-index
62
i10-index
L. Claude is an academic researcher from Institut d’Hématologie et d’Oncologie Pédiatrique. The author has contributed to research in topics: Advanced Radiotherapy Techniques & Glioma Diagnosis and Treatment & Lung Cancer Diagnosis and Treatment. The author has an h-index of 28, co-authored 183 publications.
ORCID: 0000-0002-2311-0531Papers by this author
worksImmune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
2021 · ESMO Open · 30 citations
https://doi.org/10.1016/j.esmoop.2020.100044
Implementation of Linac-based VMAT total body irradiation technique on Elekta platform using surface-guided radiation therapy
2025 · Physica Medica · 4 citations
https://doi.org/10.1016/j.ejmp.2025.104940
849: Relapse Risk stratification in pediatric ependymoma patients using clinical data and radiomics
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)01371-9
722: Standard versus highly hypofractionated tumor irradiation in LA-NSCLC with durvalumab consolidation
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)01269-6
1130: Hypofractionated SBRT in locally relapsed ependymoma: a national prospective study (NCT02013297)
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)01593-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat